Prelude Therapeutics Inc
NASDAQ:PRLD
Income Statement
Earnings Waterfall
Prelude Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-137.5m
USD
|
Operating Income
|
-137.5m
USD
|
Other Expenses
|
12m
USD
|
Net Income
|
-125.5m
USD
|
Income Statement
Prelude Therapeutics Inc
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | |||||||||||||||
Operating Expenses |
(59)
|
(60)
|
(87)
|
(100)
|
(114)
|
(122)
|
(124)
|
(123)
|
(124)
|
(122)
|
(125)
|
(128)
|
(132)
|
(138)
|
|
Selling, General & Administrative |
(11)
|
(13)
|
(19)
|
(24)
|
(27)
|
(29)
|
(32)
|
(31)
|
(31)
|
(30)
|
(30)
|
(29)
|
(29)
|
(29)
|
|
Research & Development |
(48)
|
(46)
|
(69)
|
(76)
|
(87)
|
(93)
|
(92)
|
(92)
|
(93)
|
(92)
|
(96)
|
(99)
|
(103)
|
(109)
|
|
Operating Income |
(59)
N/A
|
(60)
-1%
|
(87)
-47%
|
(100)
-15%
|
(114)
-14%
|
(122)
-7%
|
(124)
-1%
|
(123)
+0%
|
(124)
0%
|
(122)
+1%
|
(125)
-2%
|
(128)
-2%
|
(132)
-3%
|
(138)
-4%
|
|
Pre-Tax Income | |||||||||||||||
Total Other Income |
2
|
2
|
3
|
2
|
2
|
2
|
3
|
4
|
8
|
9
|
9
|
11
|
10
|
12
|
|
Pre-Tax Income |
(57)
N/A
|
(57)
-1%
|
(84)
-47%
|
(98)
-17%
|
(112)
-14%
|
(120)
-7%
|
(120)
0%
|
(120)
+1%
|
(115)
+4%
|
(114)
+2%
|
(117)
-3%
|
(117)
-1%
|
(122)
-4%
|
(126)
-3%
|
|
Net Income | |||||||||||||||
Income from Continuing Operations |
(57)
|
(57)
|
(84)
|
(98)
|
(112)
|
(120)
|
(120)
|
(120)
|
(115)
|
(114)
|
(117)
|
(117)
|
(122)
|
(126)
|
|
Net Income (Common) |
(57)
N/A
|
(57)
-1%
|
(84)
-47%
|
(98)
-17%
|
(112)
-14%
|
(120)
-7%
|
(120)
0%
|
(120)
+1%
|
(115)
+4%
|
(114)
+2%
|
(117)
-3%
|
(117)
-1%
|
(122)
-4%
|
(126)
-3%
|
|
EPS (Diluted) |
-4.56
N/A
|
-1.27
+72%
|
-1.82
-43%
|
-2.11
-16%
|
-2.43
-15%
|
-2.54
-5%
|
-2.54
N/A
|
-2.54
N/A
|
-2.44
+4%
|
-2.39
+2%
|
-2.07
+13%
|
-1.73
+16%
|
-2.02
-17%
|
-1.65
+18%
|